Stewart Information Services (STC) reported Q4 results exceeding expectations, driven by stronger commercial activity and resilient agency services. Revenues rose across all lines, with the national commercial services unit up 49% in the quarter. The acquisition of Mortgage Contracting Services expanded the lender services portfolio.

Key watchpoints include execution of targeted acquisitions to boost commercial market share, margin expansion from operational scale and technology, and a potential sustained recovery in existing home sales. STC closed at $70.93, up from $68.86 before the earnings.

Markel Group (NASDAQ: MKL) reported Q4 results driven by operational improvements in its insurance segment and broad contributions across diversified businesses. Management credited higher operating margins to exits from underperforming lines and a renewed focus on profitable growth, alongside favorable reserve releases and strong international insurance performance.

Analysts are closely watching: the pace of margin expansion from restructuring, cost synergies from AI and technology investments, and resilience of premium growth in international and financial segments amid evolving conditions. Execution on underwriting discipline and tech deployment will be key.

MKL closed at $2,102, up from $2,054 pre-earnings. The stock is at an inflection point, but timing a buy or sell depends on how effectively the company executes its strategic and operational changes.

Kemper (KMPR) posted Q4 revenue and earnings below estimates, closing at $32.51 versus $38.50 before the earnings, amid weakness in its Specialty Auto segment driven by higher California bodily injury claim severity and mandatory refunds in Florida due to statutory profit limits. Life Insurance delivered stable cash flow but couldn't offset auto volatility.

Analysts are closely watching: California auto rate increases, new auto products in Florida and Texas, realization of restructuring savings, capital allocation discipline, and policy growth outside California. Management cited regulatory changes and rising legal system costs as contributing factors.

Alphabet (GOOGL) reported Q4 revenue growth driven by accelerated AI product adoption in Search and Gemini, strong momentum in Google Cloud, and expanded consumer and subscription services. The company launched Gemini 3 and is integrating advanced AI models, while expanding its own AI infrastructure and enterprise solutions.

Key watchpoints include the pace of AI monetization in Search and Gemini, scaling Google Cloud amid supply constraints, balancing infrastructure investments with margins, and execution of new ad formats and Waymo’s international expansion. Alphabet closed at $318.85, down from $333.04 from the earnings event on February 9, 2026.

Asian equities opened mixed Monday, February 11, 2026, as investors reacted to China's January consumer price index (CPI) of 0.9% year-on-year, below consensus for a second consecutive month. The reading, part of a broader basket of measures signaling continued low inflationary pressures, prompted bets on accommodative monetary policy and tempered risk sentiment.

Supporting data showed a 1.2% year-on-year rise in core CPI (excluding food and energy) and a 4.8% increase in producer price index (PPI), highlighting persistent cost pressures for manufacturers. The Shanghai Composite (SHCI) and Hang Seng (HSI) declined, while the Tokyo Nikkei 225 (TOPIX) edged higher amid cautious optimism over potential rate cuts by the People's Bank of China.

Upstream Bio (UPBS) will present results from its Phase 2 VALIANT trial evaluating its monoclonal anti-IgE therapy in patients with severe asthma during a virtual meeting of the American Thoracic Society today, February 11, 2026.

The trial enrolled 304 adults with severe asthma and measured trough anti-IgE levels and key respiratory endpoints. If results show clinically meaningful improvement, the company may seek regulatory approval in the first half of 2026.

Eurostoxx 600 shares closed 0.8% lower on February 11, 2026, amid a deluge of earnings reports. Key decliners included Unilever (-2.1%) and Nestlé (-1.5%). The broader FTSEurostoxx 3555 index fell 0.6% on the day. Volatility rose as companies reported疲软 consumer demand and pricing pressures. Notably, German DAX成份 stocks led the decline, with Adidas (-1.8%) and Puma (-1.4%) posting significant weakness. The earnings season is ongoing, with major banks and industrials scheduled for releases in the coming weeks.

Net profit for Ahold Delhaize (AHOLD) rose to $149 million in Q4 2025, up 12.3% from $133 million in Q4 2024. The company raised its quarterly dividend by 10% to $0.20 per share, citing stronger-than-expected performance and disciplined cost management. Management expects FY2026 earnings to grow by 4%–6% year-over-year, supported by continued gains in North America and Europe. Revenue for the quarter reached $1.95 billion, reflecting improved traffic and pricing.

Skanska (SKANS) and HDR, Inc. (HDR) announced a joint venture win for a $534 million transportation infrastructure project in New York. The contract, awarded February 11, 2026, spans the reconstruction of a key arterial road and associated utilities, with construction scheduled to begin in 2026 and wrap by 2028.

The project, valued at $534 million, is the largest awarded to the Skanska-HDR joint venture in the U.S., reflecting strong execution in the transportation infrastructure segment. The agreement is expected to create approximately 1,200 construction jobs over its duration.

Nasus Pharma (NASDAQ:NASU) closed a private placement on February 11, 2026, raising $15 million by issuing 2.5 million shares of common stock and warrants to subscribe for 1.25 million shares at $6 per share. The proceeds will support the company's ongoing clinical trials and expansion of its U.S. salesforce. The company stated the funding reflects confidence in its lead candidate, NUS-101, a potential treatment for rare genetic disorders.

Meritz Financial (MERZ) released Q4 2025 results showing a 12% year-over-year decline in net income to $34.5 million, ending a losing streak of four consecutive quarters. The drop followed a 10-basis-point rise in its net interest margin, partially offset by a 20% increase in non-interest income driven by higher loan origination fees and gains from trading operations. CEO James W. Johnson attributed the decline to higher loan loss provisions and lower deposit growth, noting a 15% year-over-year contraction in total deposits as of December 31, 2025.

Barratt Redrow (BRE:UK) reported first-half profit up 13% to £117.4 million, driven by strong demand in its key markets. The company revised full-year adjusted profit guidance to £1.2 billion, in line with analyst expectations, citing improved sales and cost controls. However, it announced a 20% cut in its dividend, to 1.5p per share, citing strategic investments and macroeconomic headwinds. The cut followed a 3.5% drop in its share price on the announcement.

EU leaders are urged to simplify cross-border business regulations to enhance competitiveness and reduce fragmentation. President Ursula von der Leyen highlighted 27 distinct financial supervisory systems and over 300 trading venues as barriers to a unified capital market. She advocates a single, deep, and liquid market as part of the Savings and Investment Union. A joint single market roadmap to 2028 with a clear timetable is expected to be endorsed at the March EU summit.

Hyundai Motor Group's Boston Dynamics (BDX) announced on February 11, 2026, that Robert Playter, its chief executive, is stepping down. The move follows the automaker's acquisition of the robotics unit in 2021 with a majority stake.

Hyundai Motor (005373.KS) shares rose 5.9% on the Seoul exchange as investors expect the leadership change to accelerate the commercialization of the robot business. A report of Boston Dynamics' robot dogs being deployed at a British nuclear power plant also contributed to the gains.

In January 2026, Hyundai stated plans to deploy humanoid robots at its U.S. manufacturing plant in Georgia. Kia (005040.KS) shares gained 4.6% on the same day.

The Hong Kong Securities and Futures Commission (SFC) is set to publish a high-level framework enabling trading platforms to offer perpetual futures contracts, according to SFC CEO Julia Leung, released Feb 11, 2026. These products will initially be available only to institutional investors, with a focus on risk management and fairness. The SFC will also allow brokers to provide financing to eligible clients, with collateral backed by bitcoin (BTC) and ether (ETH), as volatility in virtual assets necessitates a cautious approach. Market-making through independent units will be required to mitigate conflicts of interest.

CEO Sheldon Z. Adelson announced on February 11, 2026, that the company is restructuring its balance sheet and strengthening its financial position through a combination of deleveraging and capital management initiatives. The plan includes a $500 million share repurchase program and a reduction in debt-to-equity ratio from 3.8x to 2.5x by 2026. The company cited pressure from regulatory changes and macroeconomic headwinds as key drivers, with management stating the measures aim to improve liquidity and reduce borrowing costs. (LVS: 14.55, -0.75%)

The U.S. Food and Drug Administration has issued a refusal-to-file letter for Moderna-MSFT's investigational flu vaccine candidate mRNA-1010, citing insufficient data to support its safety and efficacy. The decision follows a review of the company's Biologics License Application submitted in December 2025. Moderna's stock fell 3.2% in early trading on February 11, 2026, reflecting the market's negative reaction. The company plans to address the deficiencies and resubmit the application, pending additional clinical trial data.

SGS (NYSE: SGS) released results for fiscal 2025, reporting higher-than-expected revenue and earnings, with revenue up 4.2% to $3.12 billion and net income rising 8.5% to $248 million. The company reiterated a positive sales growth outlook for fiscal 2026, citing recovery in global markets and continued demand for its testing, certification, and inspection services. Management confirmed its guidance for fiscal 2027 remains intact, reflecting confidence in stabilizing demand and margin expansion.

Heineken N.V. (HEINE) reported full-year 2025 profit of EUR471 million, up 12% from EUR420 million in FY24, driven by higher pricing and cost optimization. Revenue reached EUR8.9 billion, a 2.3% increase year-over-year. The Netherlands-based brewer attributed growth to strong demand in key markets and disciplined expense management. Management guidance for FY2026 remains unchanged, reflecting continued momentum in its core beer portfolio and strategic market entry plans.

[Para 1: The Lead]

Anthropic released its 2026 Agentic Coding Trends report, forecasting a paradigm shift in software development as natural-language agents coordinate across teams, transforming engineers into orchestrators, architects, and decision-makers.

[Para 2: Supporting Details & Context]

The report outlines eight trends: extended and autonomous agent lifecycles enabling day-to-week task runs, shift from single to multi-agent coordination with explicit compilers, and broad adoption across non-technical roles. AI is expected to cut project timelines from months to days, expand output beyond traditional engineers, and compress the time engineers spend coding while amplifying total delivery. Internal studies show about 60% of engineering work now uses AI, with 27% of tasks previously not undertaken becoming viable with automation. The report also highlights implications for cybersecurity, where the same capabilities enhance defense and expand attack vectors, urging early integration of safety into agent workflows and systems.